Ezaki Glico (TSE:2206) opened Q1 2026 with revenue of ¥85.3b and basic EPS of ¥56.44, while trailing 12 month EPS stands at ¥96.92 on revenue of ¥369.3b, setting a clear earnings and top line backdrop for the latest quarter. Over recent periods, reported revenue has ranged from ¥77.3b in Q1 2025 to ¥100.2b in Q3 2025, with basic EPS moving between a loss of ¥35.06 in Q4 2025 and a profit of ¥56.44 in Q1 2026. This leaves investors focused on how consistently the current 1.7% net margin profile can be maintained.

See our full analysis for Ezaki Glico.

With the headline numbers on the table, the next step is to see how these results line up with the widely followed narratives around Ezaki Glico's growth potential, risks, and profitability story.

Curious how numbers become stories that shape markets? Explore Community Narratives

TTM EPS Growth With Mixed Longer History

• Trailing 12 month EPS is ¥96.92, about 13.2% higher than a year ago, while the five year trend shows earnings declining at about 13.9% per year.
• What stands out for a bullish view is that recent quarters show positive net income of ¥3,583m in Q1 2026 and ¥3,524m in Q3 2025, yet this sits beside earlier losses of ¥2,232m in Q4 2025 and ¥103m in Q4 2024, which means any claim of a clean earnings recovery needs to account for how uneven that pattern has been.
  • Supporters pointing to the ¥6,166m of net income over the latest 12 months have some recent momentum on their side, but critics can counter that the longer term decline rate in EPS signals that this improvement has not been consistent across years.
  • For you as an investor, the mix of a higher trailing EPS and a negative five year earnings trend makes it important to separate shorter term swings like those loss quarters from what you think is sustainable.

To see how these mixed earnings trends fit into a broader story of growth and risk for Ezaki Glico, it helps to look beyond the raw numbers and into the narratives investors are building around them.Curious how numbers become stories that shape markets? Explore Community Narratives

DCF Fair Value Versus 56.4x P/E

• The stock trades at ¥5,511 with a P/E of 56.4x, which is higher than both the JP Food industry average of 15.3x and peer average of 19.7x, while the indicated DCF fair value is ¥8,684.80.
• What challenges a purely bearish take on valuation is that even with a much richer P/E multiple than industry and peers, the DCF output still sits above the current price, so investors who are cautious about the 56.4x figure need to weigh that against a model pointing to potential upside from ¥5,511 to the DCF fair value.
  • Skeptics often focus on the gap between 56.4x and the 15.3x industry average as a sign that expectations are already high, yet on the other side of the argument, the difference between the share price and the DCF fair value suggests the current market level is not pricing the stock at that model’s estimate.
  • If you are valuation focused, the tension here is clear. The market multiple looks expensive on a simple P/E comparison, while the cash flow based estimate points in the opposite direction.

1.7% Net Margin And Dividend Coverage

• Net margin on the trailing 12 months is 1.7%, in line with the previous year, and a ¥4.4b one off loss sits in that period while the dividend yield of 1.72% is flagged as not being well covered by earnings.
• What investors watching income should pay attention to is that a flat 1.7% margin combined with a one off loss and only partially covered dividends suggests the cautious or bearish view on payout sustainability is grounded in the data rather than just opinion.
  • Critics highlight that even with total trailing revenue of ¥369.3b, the ¥6,166m of net income leaves a relatively small profit pool to support dividends, especially once the one off loss is factored into how resilient those profits look.
  • If you are considering the stock for yield, these figures make it important to stress test how comfortable you are with a payout that is described as not well covered on trailing earnings.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Ezaki Glico's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

Given the mix of concerns and optimism in these results, it makes sense to look at the underlying data yourself and weigh both sides. To pressure test your own thesis before acting, make sure you understand the 3 key rewards and 2 important warning signs

See What Else Is Out There

Ezaki Glico combines a rich 56.4x P/E, thin 1.7% net margin, uneven earnings history and dividends that are described as not well covered by earnings.

If those profit and dividend pressures make you cautious about relying on this stock alone, compare it with the solid balance sheet and fundamentals stocks screener (37 results) to find companies with sturdier financial footing and potentially more resilient payouts.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.